Safety of inhaled levofloxacin in people with cystic fibrosis: Data from UK and German Registries.
Saved in:
| Title: | Safety of inhaled levofloxacin in people with cystic fibrosis: Data from UK and German Registries. |
|---|---|
| Authors: | Simmonds NJ; Adult Cystic Fibrosis Centre, Royal Brompton Hospital, London, United Kingdom; National Heart and Lung Institute, Imperial College, London, United Kingdom. Electronic address: nicholasjames.simmonds@nhs.net., Charman SC; Cystic Fibrosis Trust, London, United Kingdom., Wosniok J; Interdisciplinary Center for Clinical Trials Mainz, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany., Haugh C; Cystic Fibrosis Trust, London, United Kingdom., Santoro D; Global Clinical Development, Chiesi Farmaceutici S.p.A., Parma, Italy., Fiorini S; Global Regulatory Affairs and Patient Safety, Chiesi Farmaceutici S.p.A., Parma, Italy., Charretier R; Global Clinical Development, Chiesi SAS, Paris, France., Sanchez C; Global Clinical Development, Chiesi Farmaceutici S.p.A., Parma, Italy., Procaccianti C; Global Medical Affairs, Chiesi Farmaceutici S.p.A., Parma, Italy., Naehrlich L; Department of Pediatrics, Justus-Liebig- University Giessen, Giessen, Germany. |
| Source: | Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society [J Cyst Fibros] 2026 Mar 18. Date of Electronic Publication: 2026 Mar 18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101128966 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-5010 (Electronic) Linking ISSN: 15691993 NLM ISO Abbreviation: J Cyst Fibros Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41856902 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Safety of inhaled levofloxacin in people with cystic fibrosis: Data from UK and German Registries. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Simmonds+NJ%22">Simmonds NJ</searchLink>; Adult Cystic Fibrosis Centre, Royal Brompton Hospital, London, United Kingdom; National Heart and Lung Institute, Imperial College, London, United Kingdom. Electronic address: nicholasjames.simmonds@nhs.net.<br /><searchLink fieldCode="AU" term="%22Charman+SC%22">Charman SC</searchLink>; Cystic Fibrosis Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Wosniok+J%22">Wosniok J</searchLink>; Interdisciplinary Center for Clinical Trials Mainz, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.<br /><searchLink fieldCode="AU" term="%22Haugh+C%22">Haugh C</searchLink>; Cystic Fibrosis Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Santoro+D%22">Santoro D</searchLink>; Global Clinical Development, Chiesi Farmaceutici S.p.A., Parma, Italy.<br /><searchLink fieldCode="AU" term="%22Fiorini+S%22">Fiorini S</searchLink>; Global Regulatory Affairs and Patient Safety, Chiesi Farmaceutici S.p.A., Parma, Italy.<br /><searchLink fieldCode="AU" term="%22Charretier+R%22">Charretier R</searchLink>; Global Clinical Development, Chiesi SAS, Paris, France.<br /><searchLink fieldCode="AU" term="%22Sanchez+C%22">Sanchez C</searchLink>; Global Clinical Development, Chiesi Farmaceutici S.p.A., Parma, Italy.<br /><searchLink fieldCode="AU" term="%22Procaccianti+C%22">Procaccianti C</searchLink>; Global Medical Affairs, Chiesi Farmaceutici S.p.A., Parma, Italy.<br /><searchLink fieldCode="AU" term="%22Naehrlich+L%22">Naehrlich L</searchLink>; Department of Pediatrics, Justus-Liebig- University Giessen, Giessen, Germany. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101128966%22">Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society</searchLink> [J Cyst Fibros] 2026 Mar 18. <i>Date of Electronic Publication: </i>2026 Mar 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>101128966 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-5010 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215691993%22">15691993 </searchLink><i>NLM ISO Abbreviation: </i>J Cyst Fibros <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41856902 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jcf.2026.03.012 Languages: – Code: eng Text: English Titles: – TitleFull: Safety of inhaled levofloxacin in people with cystic fibrosis: Data from UK and German Registries. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Simmonds NJ – PersonEntity: Name: NameFull: Charman SC – PersonEntity: Name: NameFull: Wosniok J – PersonEntity: Name: NameFull: Haugh C – PersonEntity: Name: NameFull: Santoro D – PersonEntity: Name: NameFull: Fiorini S – PersonEntity: Name: NameFull: Charretier R – PersonEntity: Name: NameFull: Sanchez C – PersonEntity: Name: NameFull: Procaccianti C – PersonEntity: Name: NameFull: Naehrlich L IsPartOfRelationships: – BibEntity: Dates: – D: 18 M: 03 Text: 2026 Mar 18 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1873-5010 Titles: – TitleFull: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society Type: main |
| ResultId | 1 |
